Skip to main content
CRBP
NASDAQ Life Sciences

Corbus Doses First Patient in Registrational TEMPO-1 Trial for CRB-701

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$7.08
Mkt Cap
$133.842M
52W Low
$6.325
52W High
$20.56
52W Position info
12% above low
Off High info
66% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

CRBP is trading near its 52-week low of $6.325 (12% above the low).

Summary

Corbus has dosed the first patient in its TEMPO-1 registrational study of CRB-701 in second-line oropharyngeal cancer. This follows FDA clearance in July and marks the official start of the pivotal trial. The study will enroll 250 patients and compare CRB-701 against investigator's choice of capecitabine, cetuximab, or docetaxel, with ORR as the primary endpoint for potential accelerated approval. Prior Phase 1/2 data showed a 42.9% confirmed ORR at the 3.6 mg/kg dose, supporting the registrational design. The company is also advancing CRB-913 in obesity, with positive Phase 1b data reported earlier this month.

At the time of this announcement, CRBP was trading at $7.08 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $133.8M. The 52-week trading range was $6.33 to $20.56. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

CRBP - Latest Insights

CRBP
Nov 10, 2026, 8:08 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.52
Real-time Price: $3.67 info
Change: +$0.154 (+4%) info
Market Cap: $69.857M info
CRBP
Sep 14, 2026, 7:06 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $9.26
Real-time Price: $3.67 info
Change: -$5.59 (-60%) info
Market Cap: $69.857M info
CRBP
Sep 14, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $8.91
Real-time Price: $3.67 info
Change: -$5.24 (-59%) info
Market Cap: $69.857M info
CRBP
Aug 07, 2026, 4:33 PM EDT
Filing Type: 424B5
Importance Score:
7
Price at Filing: $9.77
Real-time Price: $3.67 info
Change: -$6.10 (-62%) info
Market Cap: $69.857M info
CRBP
Aug 06, 2026, 4:35 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $9.65
Real-time Price: $3.67 info
Change: -$5.97 (-62%) info
Market Cap: $69.857M info